Specialized Community Disease Management to Reduce Substance Use and Hospital Readmissions
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02059005|
Recruitment Status : Completed
First Posted : February 11, 2014
Results First Posted : August 10, 2018
Last Update Posted : August 10, 2018
|Condition or disease||Intervention/treatment||Phase|
|Drug Use Alcohol Use Congestive Heart Failure Pneumonia Acute Myocardial Infarction Diabetes Mellitus Chronic Obstructive Pulmonary Disease End-Stage Renal Disease||Behavioral: Specialized Community Disease Management Behavioral: Treatment As Usual||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||97 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Specialized Community Disease Management to Reduce Substance Use and Hospital Readmissions|
|Actual Study Start Date :||November 18, 2014|
|Actual Primary Completion Date :||February 16, 2017|
|Actual Study Completion Date :||February 28, 2017|
Experimental: Specialized Community Disease Management
Specialized Community Disease Management
Behavioral: Specialized Community Disease Management
Specialized Community Disease Management is 90-day program that employs specialized teams including a trained clinical social worker and a peer-specialist community health worker who provide evidence-based telephone continuing care, home visits, and focus on patients' substance use following hospital discharge.
Active Comparator: Treatment As Usual
Treatment as Usual: standard post-hospital discharge with medical monitoring.
Behavioral: Treatment As Usual
Treatment as Usual is a 90-day, post-discharge program that consists of medical monitoring by nurses and community health workers who have no special training in working with substance use disorder patients, and does not address substance use.
- Change in Substance Use Rates From Baseline [ Time Frame: 0, 3, 6 months ]Urinalysis confirmed self-reported days of use for any substance, including alcohol, cocaine, marijuana, opiates, sedatives, and hallucinogens over time. Participants reported substance use for the 90 days prior to the assessment date.
- Change in Treatment Session Attendance From Baseline [ Time Frame: 0, 3, 6, months ]Treatment sessions attended for alcohol or drug use issues over time. Participants self-reported attendance for the 6 months prior to the baseline assessment. During follow-up assessments, participants self-reported attendance since the last assessment date.
- Number of Hospitalizations and Use of Emergency Services [ Time Frame: 0, 3, 6, months ]Days of hospitalization and days of use of acute emergency services after Baseline. Participants self-reported their service utilization for the 6 months prior to the baseline assessment. During follow-up assessments, participants self-reported their service utilization since the last assessment date.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02059005
|United States, Pennsylvania|
|Temple University Hospital|
|Philadelphia, Pennsylvania, United States, 19140|
|Principal Investigator:||Adam C Brooks, PhD||Treatment Research Institute|